ACAD
Acadia Pharmaceuticals Inc. · Healthcare
CEO Stephen Davis sold $112K of Acadia Pharmaceuticals Inc.
Sold$111,811
$29.96Price
3,732Shares
−4%Stake
What ACAD did after the filing
- The stock from Tue, Jan 9 close, $30.66
- −18.9%
- S&P 500, same days
- +7.1%
Measured over 30 trading days, to the Feb 22 close.
Traded Mon, Jan 8. Filed Tue, Jan 9, 1:00 PM ET, during the session. Returns use the Jan 9 close and the Feb 22 close. Not investment advice.